🇺🇸 Initial triple combination in United States

Initial triple combination (Initial triple combination) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Initial triple combination in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Initial triple combination approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Initial triple combination in United States?

Seoul National University Bundang Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.